COVID-19 and Obesity: Epidemiology, Pathogenesis and Treatment
Xinyu Zhu,1,2,* Liu Yang,1,2,* Kai Huang1,2 1Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China; 2Clinical Center for Human Genomic Research, Union Hospital, Tongji Medical College, Huazh...
Guardado en:
Autores principales: | Zhu X, Yang L, Huang K |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/5c07689644e643b38e77c84cbab4f7a1 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Impact of Obesity and Its Associated Comorbid Conditions on COVID-19 Presentation
por: Mehanna O, et al.
Publicado: (2021) -
Bangladesh Endocrine Society (BES) Position Statement for Management of Diabetes and Other Endocrine Diseases in Patients with COVID-19
por: Pathan F, et al.
Publicado: (2021) -
Pathogenesis of the initial stages of severe COVID-19
por: Alexander S. Golota, et al.
Publicado: (2021) -
Eating Behavior Changes of People with Obesity During the COVID-19 Pandemic
por: Bayram Deger V
Publicado: (2021) -
Long‐term effects of obesity on COVID‐19 patients discharged from hospital
por: Luorui Shang, et al.
Publicado: (2021)